Blood oxidative stress markers in Gaucher disease patients
Authors:
- Fernanda M. RoversiFRFernanda M. Roversi
- Luciano C. GaldieriLGLuciano C. Galdieri
- Bruno H.C. GregoBGBruno H.C. Grego
- Fernanda G. SouzaFSFernanda G. Souza
- Cecília MichelettiCMCecília Micheletti
- Ana Maria MartinsAMAna Maria Martins
- Vânia D'ALmeidaVDVânia D'ALmeida
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 364 (1-2) , 316-320
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Homocysteine as a neurotoxin in chronic alcoholismProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2004
- Gaucher disease: lessons from a decade of therapyThe Journal of Pediatrics, 2004
- Glucocerebroside inhibits NADPH oxidase activation in cell-free systemBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Gaucher DiseaseAJN, American Journal of Nursing, 2003
- Enzyme Therapy for Lysosomal Storage Disease: Principles, Practice, and ProspectsAnnual Review of Genomics and Human Genetics, 2003
- Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifidaAmerican Journal of Medical Genetics Part A, 2002
- HOMOCYSTEINE METABOLISMAnnual Review of Nutrition, 1999
- A Second Common Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects?The American Journal of Human Genetics, 1998
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Increased biliary glutathione disulfide release in chronically ethanol‐treated ratsFEBS Letters, 1979